ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM),…
ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025
Study data also showed prolonged progression-free survival with 177Lu-edotreotide compared to everolimus…
Individual Neutral Athletes to compete at Milano Cortina 2026 Olympic Winter Games under same conditions as for Paris 2024
19 September 2025 - Individual Neutral Athletes (AIN) who have qualified through the…
Royal Meteorological Society’s Public Vote Open: 25 Striking Images Compete in the Standard Chartered Weather Photographer of the Year 2025 Competition
LONDON, Sept. 18, 2025 /PRNewswire/ -- From 18 September to 16 October,…
